Effects of semaglutide, empagliflozin and their combination on renal diffusion-weighted MRI and total kidney volume in patients with type 2 diabetes: a post hoc analysis from a 32 week randomised trial.
Liv VernstrømSøren GullaksenSteffen S SørensenSteffen RinggaardChristoffer LaustsenHenrik BirnKristian Løkke FunckEsben LaugesenPer Løgstrup PoulsenPublished in: Diabetologia (2024)
European Union Drug Regulating Authorities Clinical Trials Database (EudraCT) 2019-000781-38.
Keyphrases
- diffusion weighted
- contrast enhanced
- clinical trial
- magnetic resonance imaging
- adverse drug
- open label
- magnetic resonance
- study protocol
- computed tomography
- diffusion weighted imaging
- phase ii
- placebo controlled
- double blind
- phase iii
- emergency department
- randomized controlled trial
- drug induced
- electronic health record